Pfizer, joining Lilly, enters the direct-to-consumer market with a telehealth and prescription platform

Published On Aug 27, 2024, 8:02 AM

Pfizer is entering the direct-to-consumer market with a new telehealth and prescription platform, following in the footsteps of Eli Lilly. This initiative aims to provide a convenient way for patients to access medications and health services, targeting a growing trend in telehealth and online prescription services.

Stock Forecasts

Pfizer's entry into direct-to-consumer telehealth services aligns with current healthcare trends, potentially increasing their customer base and revenue streams. This move could enhance their competitive positioning in the pharmaceutical industry.

Related News

Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald Trump is a wild card.

PFE
XBI

Investors have overhauled their views on interest rate cuts after a blowout jobs report, ahead of a week of key inflation data and the start of earnings season.

PFE
NVDA
AMZN

Investors have overhauled their views on interest rate cuts after a blowout jobs report, ahead of a week of key inflation data and the start of earnings season.

GOOGL
XLE
NVDA
PFE